303 related articles for article (PubMed ID: 34318743)
1. Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT.
Wu O; McCartney E; Heggie R; Germeni E; Paul J; Soulis E; Dillon S; Ryan C; Sim M; Dixon-Hughes J; Agarwal R; Bodenham A; Menne T; Jones B; Moss J
Health Technol Assess; 2021 Jul; 25(47):1-126. PubMed ID: 34318743
[TBL] [Abstract][Full Text] [Related]
2. Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial.
Moss JG; Wu O; Bodenham AR; Agarwal R; Menne TF; Jones BL; Heggie R; Hill S; Dixon-Hughes J; Soulis E; Germeni E; Dillon S; McCartney E;
Lancet; 2021 Jul; 398(10298):403-415. PubMed ID: 34297997
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
Gilbert R; Brown M; Faria R; Fraser C; Donohue C; Rainford N; Grosso A; Sinha AK; Dorling J; Gray J; Muller-Pebody B; Harron K; Moitt T; McGuire W; Bojke L; Gamble C; Oddie SJ
Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
[TBL] [Abstract][Full Text] [Related]
4. Patient acceptability of three different central venous access devices for the delivery of systemic anticancer therapy: a qualitative study.
Ryan C; Hesselgreaves H; Wu O; Moss J; Paul J; Dixon-Hughes J; Germeni E
BMJ Open; 2019 Jul; 9(7):e026077. PubMed ID: 31292176
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of peripherally inserted central catheter and other venous access devices: A scoping review.
Wang K; Zhong J; Huang N; Zhou Y
J Vasc Access; 2020 Nov; 21(6):826-837. PubMed ID: 31894710
[TBL] [Abstract][Full Text] [Related]
6. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
[TBL] [Abstract][Full Text] [Related]
7. Shockwave lithotripsy compared with ureteroscopic stone treatment for adults with ureteric stones: the TISU non-inferiority RCT.
Dasgupta R; Cameron S; Aucott L; MacLennan G; Kilonzo MM; Lam TB; Thomas R; Norrie J; McDonald A; Anson K; N'Dow J; Burgess N; Clark CT; Keeley FX; MacLennan SJ; Starr K; McClinton S
Health Technol Assess; 2022 Mar; 26(19):1-70. PubMed ID: 35301982
[TBL] [Abstract][Full Text] [Related]
8. Peripherally inserted central catheter versus totally implanted venous port for delivering medium- to long-term chemotherapy: A cost-effectiveness analysis based on propensity score matching.
Wang K; Zhou Y; Huang N; Lu Z; Zhang X
J Vasc Access; 2022 May; 23(3):365-374. PubMed ID: 33579176
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.
Taxbro K; Hammarskjöld F; Thelin B; Lewin F; Hagman H; Hanberger H; Berg S
Br J Anaesth; 2019 Jun; 122(6):734-741. PubMed ID: 31005243
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic supracervical hysterectomy compared with second-generation endometrial ablation for heavy menstrual bleeding: the HEALTH RCT.
Cooper K; Breeman S; Scott NW; Scotland G; Hernández R; Clark TJ; Hawe J; Hawthorn R; Phillips K; Wileman S; McCormack K; Norrie J; Bhattacharya S
Health Technol Assess; 2019 Sep; 23(53):1-108. PubMed ID: 31577219
[TBL] [Abstract][Full Text] [Related]
11. 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Iveson T; Boyd KA; Kerr RS; Robles-Zurita J; Saunders MP; Briggs AH; Cassidy J; Hollander NH; Tabernero J; Haydon A; Glimelius B; Harkin A; Allan K; McQueen J; Pearson S; Waterston A; Medley L; Wilson C; Ellis R; Essapen S; Dhadda AS; Harrison M; Falk S; Raouf S; Rees C; Olesen RK; Propper D; Bridgewater J; Azzabi A; Farrugia D; Webb A; Cunningham D; Hickish T; Weaver A; Gollins S; Wasan H; Paul J
Health Technol Assess; 2019 Dec; 23(64):1-88. PubMed ID: 31852579
[TBL] [Abstract][Full Text] [Related]
12. Cognitive-behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT.
Goldstein LH; Robinson EJ; Pilecka I; Perdue I; Mosweu I; Read J; Jordan H; Wilkinson M; Rawlings G; Feehan SJ; Callaghan H; Day E; Purnell J; Baldellou Lopez M; Brockington A; Burness C; Poole NA; Eastwood C; Moore M; Mellers JD; Stone J; Carson A; Medford N; Reuber M; McCrone P; Murray J; Richardson MP; Landau S; Chalder T
Health Technol Assess; 2021 Jun; 25(43):1-144. PubMed ID: 34196269
[TBL] [Abstract][Full Text] [Related]
13. Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT.
Constable L; Abrams P; Cooper D; Kilonzo M; Cotterill N; Harding C; Drake MJ; Pardoe MN; McDonald A; Smith R; Norrie J; McCormack K; Ramsay C; Uren A; Mundy T; Glazener C; MacLennan G
Health Technol Assess; 2022 Aug; 26(36):1-152. PubMed ID: 35972773
[TBL] [Abstract][Full Text] [Related]
14. Cost-utility analysis of centrally inserted totally implanted access port (PORT) vs. peripherally inserted central catheter (PICC) in the oncology chemotherapy.
Shao G; Zhou X; Zhang S; Wu S; Dong Y; Dong Z
Front Public Health; 2022; 10():942175. PubMed ID: 35937250
[TBL] [Abstract][Full Text] [Related]
15. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.
Hykin P; Prevost AT; Sivaprasad S; Vasconcelos JC; Murphy C; Kelly J; Ramu J; Alshreef A; Flight L; Pennington R; Hounsome B; Lever E; Metry A; Poku E; Yang Y; Harding SP; Lotery A; Chakravarthy U; Brazier J
Health Technol Assess; 2021 Jun; 25(38):1-196. PubMed ID: 34132192
[TBL] [Abstract][Full Text] [Related]
17. Supraglottic airway device versus tracheal intubation in the initial airway management of out-of-hospital cardiac arrest: the AIRWAYS-2 cluster RCT.
Benger JR; Kirby K; Black S; Brett SJ; Clout M; Lazaroo MJ; Nolan JP; Reeves BC; Robinson M; Scott LJ; Smartt H; South A; Stokes EA; Taylor J; Thomas M; Voss S; Wordsworth S; Rogers CA
Health Technol Assess; 2022 Apr; 26(21):1-158. PubMed ID: 35426781
[TBL] [Abstract][Full Text] [Related]
18. PICC-PORT totally implantable vascular access device in breast cancer patients undergoing chemotherapy.
Bertoglio S; Cafiero F; Meszaros P; Varaldo E; Blondeaux E; Molinelli C; Minuto M
J Vasc Access; 2020 Jul; 21(4):460-466. PubMed ID: 31674857
[TBL] [Abstract][Full Text] [Related]
19. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.
Gohel MS; Heatley F; Liu X; Bradbury A; Bulbulia R; Cullum N; Epstein DM; Nyamekye I; Poskitt KR; Renton S; Warwick J; Davies AH
Health Technol Assess; 2019 May; 23(24):1-96. PubMed ID: 31140402
[TBL] [Abstract][Full Text] [Related]
20. Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation.
Wu O; Boyd K; Paul J; McCartney E; Ritchie M; Mellon D; Kelly L; Dixon-Hughes J; Moss J
Br J Cancer; 2016 Apr; 114(9):979-85. PubMed ID: 27092784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
